Date updated:03-24-2008
No description available

-
ELY
Callaway Golf Com - $9.36
- +0.11%
- $9.36
No Analysis added

-
PFE
Pfizer - $16.91
- -1.86%
- $17.27
No Analysis added

-
T
At&t Inc. - $26.24
- +0.69%
- $26.19
No Analysis added

-
PG
Procter & Gamble - $63.84
- +0.17%
- $63.83
No Analysis added

-
SBGI
Sinclair Broadcas - $5.115
- -5.80%
- $5.40
No Analysis added

-
DIS
Walt Disney Compa - $33.64
- -0.41%
- $33.81
No Analysis added

-
INTC
Intel Corporation - $21.9925
- -0.93%
- $22.31
No Analysis added
- mbal1856 Portfolio 1's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. BlackRock Health Scien...
- 3. Calamos Advisors
- 4. Fidelity Select Pharma...
- 5. Schwab Health Care SWHFX
- show all
- Top Do-It-Yourself Portfolios
- » jgroov Portfolio 1
- » ben johnson
- » my holdings
- » SC TRADE OF THE DAY
- » kudos
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on March 19, 2010 Last week was a comparatively quiet one for dividend stocks, particularly given the slew of investor payouts that capped off...
By Roberto Pedone Posted on March 19, 2010 According to Jim Cramer, the stock market could catch a cold from health care reform. In a March 18 RealMoney blog post, he s...
By Jonas Elmerraji Posted on March 18, 2010 Short sellers beware; stocks are seeing a buyer’s market this week. Now that the S&P 500 and the Dow Jones Industrial Aver...
By Roberto Pedone Posted on March 18, 2010 According to CNBC’s “Fast Money” traders, the easy money trades are still the way to play this market after the Federal...
A. The only one I own : SLX,
too hard pick a winner out all of them
Below is a list of some of the companies that have their ex-dividend date Monday, Mar. 22, 2010. What is the ex-dividend date? According to Dividends.com: The ex-div... more
Analyst Downgrades and EPS estimate changes for Mar. 19, 2010. more
TheStreet Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its safety first approach to investing aim... more











Comments not available